It is demanded that pharmaceutical agents for therapeutic treatment of diseases such as cancer, acromegaly and diabetic complications, of which IGF is involved in the progress of the conditions.
US Patent 07498415 Recombinant antibody against human insulin-like growth factorUS Patent 7498415 Recombinant antibody against human insulin-like growth factor
Infobox
Patent Number
074984150
Patent Number
74984150
Edits on 24 May, 2023
"Remove website redirecting to Patent Public Search front page"